Evidence map›Paper›PMID 35923258›Full record

ArticleFrontiers in chemistry2022

Mouse Strain- and Charge-Dependent Vessel Permeability of Nanoparticles at the Lower Size Limit.

Haoran Chen, Yu-Cheng Liu, Zhiming Zhang, Moxin Li, Lidong Du, Pei-Chun Wu, Wai-How Chong, Fuzeng Ren, Weiming Zheng, Tzu-Ming Liu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Clearing and Masking Agents in Pretargeting Strategies.Pharmaceuticals (Basel, Switzerland) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Haoran ChenInstitute of Translational Medicine, Faculty of Health Sciences, University of Macau, Taipa, Macau SAR, China.
Yu-Cheng LiuInstitute of Translational Medicine, Faculty of Health Sciences, University of Macau, Taipa, Macau SAR, China.
Zhiming ZhangInstitute of Translational Medicine, Faculty of Health Sciences, University of Macau, Taipa, Macau SAR, China.
Moxin LiInstitute of Translational Medicine, Faculty of Health Sciences, University of Macau, Taipa, Macau SAR, China.
Lidong DuInstitute of Translational Medicine, Faculty of Health Sciences, University of Macau, Taipa, Macau SAR, China.
Pei-Chun WuInstitute of Translational Medicine, Faculty of Health Sciences, University of Macau, Taipa, Macau SAR, China.
Wai-How ChongInstitute of Translational Medicine, Faculty of Health Sciences, University of Macau, Taipa, Macau SAR, China.
Fuzeng RenDepartment of Materials Science and Engineering, Southern University of Science and Technology, Shenzhen, China.
Weiming ZhengTranslational Medicine R&D Center, Zhuhai UM Science and Technology Research Institute, Zhuhai, China.
Tzu-Ming LiuInstitute of Translational Medicine, Faculty of Health Sciences, University of Macau, Taipa, Macau SAR, China.
University of Macau · MOSouthern University of Science and Technology · CNZhuhai Institute of Advanced Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Remarkable advancement has been made in the application of nanoparticles (NPs) for cancer therapy. Although NPs have been favorably delivered into tumors by taking advantage of the enhanced permeation and retention (EPR) effect, several physiological barriers present within tumors tend to restrict the diffusion of NPs. To overcome this, one of the strategies is to design NPs that can reach lower size limits to improve tumor penetration without being rapidly cleared out by the body. Several attempts have been made to achieve this, such as selecting appropriate nanocarriers and modifying surface properties. While many studies focus on the optimal design of NPs, the influence of mouse strains on the effectiveness of NPs remains unknown. Therefore, this study aimed to assess whether the vascular permeability of NPs near the lower size limit differs among mouse strains. We found that the vessel permeability of dextran NPs was size-dependent and dextran NPs with a size below 15 nm exhibited leakage from postcapillary venules in all strains. Most importantly, the leakage rate of 8-nm fluorescein isothiocyanate dextran was significantly higher in the BALB/c mouse strain than in other strains. This strain dependence was not observed in slightly positive TRITC-dextran with comparable sizes. Our results indicate that the influence on mouse strains needs to be taken into account for the evaluation of NPs near the lower size limit.

Indexed as

charge-dependentdrug deliverylower size limitmouse strain–dependentnanoparticlestwo-photon microscopyvascular permeability

Identifiers

PMID35923258
PMCPMC9339680
OpenAlexW4285730762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.